Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy

David Lally, MD, Nikolas J.S. London, MD

Show Description +

David Lally, MD, of the Tufts New England Eye Center, Ophthalmic Consultants of Boston, discusses changes in hydroxychloroquine retinopathy after drug cessation.

Posted: 8/08/2014

Up Next

Name: Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy
Uploaded: 2014-08-08T16:17:00+00:00
Description: David Lally, MD, of the Tufts New England Eye Center, Ophthalmic Consultants of Boston, discusses changes in hydroxychloroquine retinopathy after drug cessation.

Long-Term Treatment Outcomes for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen

Carl Regillo, MD, Nikolas J.S. London, MD

Real-World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data from a Large US Health System

Nancy Holekamp MD

Results of ESBA 1008, a Single-Chain Antibody Fragment, for the Treatment of Neovascular AMD

Pravin Dugel, MD

$Dexamethasone Intravitreal Implant in Diabetic Macular Edema Patients Refractory to Conventional Therapy$

Dexamethasone Intravitreal Implant in Diabetic Macular Edema Patients Refractory to Conventional Therapy

David G. Dodwell, MD

Preview - What to Watch for in San Diego!

Rishi Singh, MD

Evaluation of Intraocular Inflammation and Pain Post Intravitreal Injection of Ranibizumab or Aflibercept: The PLANET Study

Arshad M. Khanani, MD, Nikolas J.S. London, MD

Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Nikolas J.S. London, MD, Rahul Khurana, MD

Microincisional Vitrectomy (MIVS) in the Primary Management of Uveal Malignant Melanoma: Application of Direct Tumor Ablation and Molecular Genomics

Tim Murray, MD

Next Generation Intrasurgical Imaging with a Swept-Source Microscope-Integrated Optical Coherence Tomography Device

Paul Hahn, MD

Optical Coherence Tomography Measurement of Retinal Pigment Epithelium Drusen Complex Predicts 2-Year Progression of Age-Related Macular Degeneration

Nikolas J.S. London, MD, Sumit Sharma, MD

Intraocular Pharmacokinetic Profile of Aflibercept in Patients Treated With Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Clement K. Chan, MD, FACS

Back to All Videos

Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy

David Lally, MD, Nikolas J.S. London, MD

David Lally, MD, of the Tufts New England Eye Center, Ophthalmic Consultants of Boston, discusses changes in hydroxychloroquine retinopathy after drug cessation.

Posted: 8/08/2014

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy

Up Next

Changes in Hydroxychloroquine Retinopathy Following Drug Cessation: With Expanded SD-OCT Findings to Assist in the Early Detection of Retinopathy

More From ASRS: 2014 Coverage